ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,938Medicare Part D Prescriptions Filled, Including Refills

Rank: 73 out of 1290

$1.17M Total Retail Price of All Prescriptions

Rank: 31 out of 1290

417 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 417 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

40% of this provider’s 417 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 5,495 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$118 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
HYDROCODONE-ACETAMINOPHEN 906 297 S3 1 6
SIMVASTATIN 371 255 2 1
ADVAIR DISKUS 330 176 3 37
LISINOPRIL 258 191 4 5
OMEPRAZOLE 242 128 5 2
LEVOTHYROXINE SODIUM 219 122 6 4
TRAMADOL HCL 210 101 7 25
SPIRIVA 183 136 8 75
PROAIR HFA 156 57 9 73
ZOLPIDEM TARTRATE 152 80 10 15
FUROSEMIDE 138 91 11 9
POTASSIUM CHLORIDE 136 119 12 35
AMLODIPINE BESYLATE 121 95 13 3
METFORMIN HCL 119 61 14 10
CARVEDILOL 118 96 15 12
METOPROLOL TARTRATE 115 89 16 7
LYRICA 115 42 16 94
ALLOPURINOL 114 85 18 60
AMITRIPTYLINE HCL 112 33 R 19 97
METHYLPREDNISOLONE 104 64 20 101
CLOPIDOGREL 95 58 21 24
GABAPENTIN 91 41 22 8
PLAVIX 90 66 23 32
OXYCODONE HCL-ACETAMINOPHEN 89 29 S2 24 52
ATORVASTATIN CALCIUM 79 68 25 23
COMBIVENT 75 49 26 215
VENTOLIN HFA 75 11 26 123
NAMENDA 70 60 28 27
SYMBICORT 70 50 28 109
ROPINIROLE HCL 66 30 30 146
ANTARA 66 27 30 574
ALBUTEROL SULFATE 65 20 32 319
SERTRALINE HCL 65 42 32 36
JANUVIA 64 34 34 82
ESCITALOPRAM OXALATE 63 43 35 63
HYDROCHLOROTHIAZIDE 61 40 36 20
TAMSULOSIN HCL 61 37 36 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 24 36 92
OXYBUTYNIN CHLORIDE ER 61 46 36 161
BUMETANIDE 60 56 40 196
MELOXICAM 58 16 41 31
LEVOFLOXACIN 57 31 42 150
BACLOFEN 57 0 42 122
LEVEMIR 56 36 44 256
HYDRALAZINE HCL 56 47 44 133
ENOXAPARIN SODIUM 56 26 44 306
FENOFIBRATE 55 24 47 98
CITALOPRAM HBR 55 42 47 29
LEVEMIR FLEXPEN 55 20 47 172
LEVETIRACETAM 53 23 50 70
NYSTATIN 52 31 51 440
DONEPEZIL HCL 52 49 51 13
WARFARIN SODIUM 51 21 53 22
THEOPHYLLINE ANHYDROUS 50 30 54 375
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.